Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C80H106Cl2N11O27P |
| Molecular Weight | 1755.635 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 18 / 18 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@](C)(NCCNCCCCCCCCCC)[C@H](O)[C@H](C)O1)O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC3=C4OC5=C(Cl)C=C(C=C5)[C@@H](O)[C@]6([H])NC(=O)[C@H](NC(=O)[C@@H]7NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C8=CC=C(OC3=CC7=C4)C(Cl)=C8)C9=CC=C(O)C(=C9)C%10=C(C=C(O)C(CNCP(O)(O)=O)=C%10O)[C@H](NC6=O)C(O)=O
InChI
InChIKey=ONUMZHGUFYIKPM-MXNFEBESSA-N
InChI=1S/C80H106Cl2N11O27P/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114)/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-/m0/s1
| Molecular Formula | C80H106Cl2N11O27P |
| Molecular Weight | 1755.635 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 18 / 18 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:24:11 UTC 2023
by
admin
on
Fri Dec 15 16:24:11 UTC 2023
|
| Record UNII |
XK134822Z0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C61101
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VIBATIV (AUTHORIZED: CROSS INFECTION PNEUMONIA, BACTERIAL)
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
||
|
NDF-RT |
N0000191281
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
||
|
WHO-ATC |
J01XA03
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
||
|
LIVERTOX |
927
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
||
|
WHO-VATC |
QJ01XA03
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
XK134822Z0
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
C487637
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
XK134822Z0
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
8504
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
TELAVANCIN
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
m10527
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | Merck Index | ||
|
Telavancin
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
71229
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
C87603
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
DTXSID10873383
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
4116
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
CHEMBL507870
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
8194
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
372151-71-8
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
100000089642
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
DB06402
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
N0000191280
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | Lipoglycopeptides [Chemical/Ingredient] | ||
|
SUB26698
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | |||
|
473837
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY | RxNorm | ||
|
3081362
Created by
admin on Fri Dec 15 16:24:12 UTC 2023 , Edited by admin on Fri Dec 15 16:24:12 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
